AI assistant
Sending…
RESMED INC — Director's Dealing 2013
Nov 15, 2013
30071_dirs_2013-11-15_7a39193d-f660-4e83-909f-23e9ffc897a7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-11-13
Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-13 | ResMed Stock Options | $51.25 | A | 24234 | Acquired | 2020-11-13 | ResMed Common Stock (24234) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 68955.566 | Direct |
Footnotes
F1: Represents date options first become exercisable. Options will vest 1/3 annually on 11/11/2014, 11/11/2015 and 11/11/2016.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29